Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Editas Medicine (EDIT) Other Operating Expenses (2016 - 2023)

Editas Medicine (EDIT) has disclosed Other Operating Expenses for 6 consecutive years, with -$1000.0 as the latest value for Q4 2023.

  • Quarterly Other Operating Expenses fell 200.0% to -$1000.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was -$1000.0 through Sep 2024, down 150.0% year-over-year, with the annual reading at $40.5 million for FY2016, N/A changed from the prior year.
  • Other Operating Expenses for Q4 2023 was -$1000.0 at Editas Medicine, down from $1000.0 in the prior quarter.
  • The five-year high for Other Operating Expenses was $2000.0 in Q4 2020, with the low at -$2000.0 in Q3 2022.
  • Average Other Operating Expenses over 4 years is $333.33, with a median of $1000.0 recorded in 2021.
  • Peak annual rise in Other Operating Expenses hit 200.0% in 2023, while the deepest fall reached 200.0% in 2023.
  • Over 4 years, Other Operating Expenses stood at $2000.0 in 2020, then tumbled by 50.0% to $1000.0 in 2021, then changed by 0.0% to $1000.0 in 2022, then plummeted by 200.0% to -$1000.0 in 2023.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at -$1000.0, $1000.0, and $1000.0 for Q4 2023, Q2 2023, and Q4 2022 respectively.